锡类散与美沙拉嗪缓释颗粒剂保留灌肠治疗宫颈癌放射性直肠炎的效果观察  

Effect observation of retention enema with Xilei powder and mesalazine slow-release granules to the radiation proctitis patients of the uterine cervix cancer

作　　者：冯德霞[1] 张海霞[1] 

机构地区：[1]济宁医学院附属医院肿瘤科,山东济宁272000

出　　处：《中国当代医药》2014年第23期54-55,58,共3页China Modern Medicine

摘　　要：目的探讨锡类散与美沙拉嗪缓释颗粒剂联合保留灌肠治疗宫颈癌放射性直肠炎的效果。方法将86例患者随机分为治疗组和对照组,每组各43例,对照组采用常规小牛血去蛋白提取物注射液静脉滴注与蒙脱石散剂口服治疗,治疗组在对照组的基础上,采用锡类散与美沙嗪缓释颗粒剂保留灌肠。结果治疗组患者的总有效率为100.0%,对照组为74.4%,治疗组明显优于对照组,差异有统计学意义(P<0.05)。结论锡类散与美沙拉嗪联合保留灌肠治疗宫颈癌放射性直肠炎的效果明确。Objective To discuss the effect of retention enema with Xilei powder and mesalazine slow-release granules to the radiation proctitis patients of the uterine cervix cancer. Methods 86 patients were randomly divided into treatment group and control group,each group of 43 cases,the control group were treated with drip protein-free calf blood extract injection and oral smectite powder,besides which the treatment group added retention enema with Xilei powder and mesalazine slow-release granules. Results The total effective rate of patients in the treatment group was 100.0%, while the control group was 74.4%,the curative effect in treatment group was better than that of the control group,the difference was statistically significant （P〈0.05）. Conclusion The retention enema with XilLei powder and mesalazine slow-release granules have a certain effect to the radiation proctitis patients of the uterine cervix cancer.

关 键 词：锡类散 美沙拉嗪缓释颗粒剂 放射性直肠炎 宫颈癌 保留灌肠 

分 类 号：R737.33[医药卫生—肿瘤]